Featured
-
-
Article |
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate
- Karel H. van der Pol
- , Marga Nijenhuis
- & Gerard A. Rongen
-
Article |
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)
- Maja Matic
- , Marga Nijenhuis
- & Ron H. N. van Schaik
-
Article |
A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care
- Paul C. D. Bank
- , Jesse J. Swen
- & Henk-Jan Guchelaar
-
Viewpoint |
A brighter future for the implementation of pharmacogenomic testing
- Cathelijne H van der Wouden
- , Jesse J Swen
- & Henk-Jan Guchelaar
-
Viewpoint |
The medical geneticist as expert in the transgenerational and developmental aspects of diseases
- György Kosztolányi
- & Jean-Jacques Cassiman
-
Article |
Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study
- Mingqing Xu
- , Sheng Li
- & Lin He